173 related articles for article (PubMed ID: 22707305)
1. MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells.
Annabi B; Vaillancourt-Jean E; Béliveau R
Inflammopharmacology; 2013 Feb; 21(1):91-9. PubMed ID: 22707305
[TBL] [Abstract][Full Text] [Related]
2. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
[TBL] [Abstract][Full Text] [Related]
3. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
4. A role for MT1-MMP as a cell death sensor/effector through the regulation of endoplasmic reticulum stress in U87 glioblastoma cells.
Proulx-Bonneau S; Pratt J; Annabi B
J Neurooncol; 2011 Aug; 104(1):33-43. PubMed ID: 21088866
[TBL] [Abstract][Full Text] [Related]
5. [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism].
Wang M; Cui HX; Sun C; Li G; Wang HL; Xia CH; Wang YC; Liu JC
Yao Xue Xue Bao; 2016 Apr; 51(4):558-62. PubMed ID: 29859524
[TBL] [Abstract][Full Text] [Related]
6. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Park JM; Kim A; Oh JH; Chung AS
Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
[TBL] [Abstract][Full Text] [Related]
7. Concanavalin-A triggers inflammatory response through JAK/STAT3 signalling and modulates MT1-MMP regulation of COX-2 in mesenchymal stromal cells.
Akla N; Pratt J; Annabi B
Exp Cell Res; 2012 Nov; 318(19):2498-506. PubMed ID: 22971618
[TBL] [Abstract][Full Text] [Related]
8. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
[TBL] [Abstract][Full Text] [Related]
9. Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells.
Pratt J; Roy R; Annabi B
Glycobiology; 2012 Sep; 22(9):1245-55. PubMed ID: 22692046
[TBL] [Abstract][Full Text] [Related]
10. A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells.
Annabi B; Laflamme C; Sina A; Lachambre MP; Béliveau R
J Neuroinflammation; 2009 Mar; 6():8. PubMed ID: 19272160
[TBL] [Abstract][Full Text] [Related]
11. A Transcriptional Regulatory Role for the Membrane Type-1 Matrix Metalloproteinase in Carcinogen-Induced Inflammasome Gene Expression.
Sheehy S; Annabi B
Gene Regul Syst Bio; 2017; 11():1177625017713996. PubMed ID: 28634425
[TBL] [Abstract][Full Text] [Related]
12. In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.
Gramegna P; Latronico T; Branà MT; Di Bari G; Mengoni F; Belvisi V; Mascellino MT; Lichtner M; Vullo V; Mastroianni CM; Liuzzi GM
PLoS One; 2011; 6(12):e28499. PubMed ID: 22174822
[TBL] [Abstract][Full Text] [Related]
13. Dual functions of ARP101 in targeting membrane type-1 matrix metalloproteinase: Impact on U87 glioblastoma cell invasion and autophagy signaling.
Desjarlais M; Annabi B
Chem Biol Drug Des; 2019 Mar; 93(3):272-282. PubMed ID: 30291676
[TBL] [Abstract][Full Text] [Related]
14. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
15. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
Heikkilä P; Teronen O; Hirn MY; Sorsa T; Tervahartiala T; Salo T; Konttinen YT; Halttunen T; Moilanen M; Hanemaaijer R; Laitinen M
J Surg Res; 2003 May; 111(1):45-52. PubMed ID: 12842447
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue.
Mohammad MA; Zeeneldin AA; Abd Elmageed ZY; Khalil EH; Mahdy SM; Sharada HM; Sharawy SK; Abdel-Wahab AH
Mol Cell Biochem; 2012 Jul; 366(1-2):269-75. PubMed ID: 22527932
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
19. Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride.
Hong H; Park YK; Choi MS; Ryu NH; Song DK; Suh SI; Nam KY; Park GY; Jang BC
J Dermatol Sci; 2009 Oct; 56(1):43-50. PubMed ID: 19656660
[TBL] [Abstract][Full Text] [Related]
20. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]